Viable News Team 
Gaborone – The government of Botswana has announced urgent plans to raise 2.5 billion pula (approximately R3.2 billion) by the end of September in an effort to address the country’s escalating public health crisis.
The move comes in the wake of President Duma Boko’s declaration of a state of public health emergency, following widespread reports that hospitals and clinics across the country are running out of essential medicines including antiretroviral drugs (ARVs) critical to the fight against HIV/AIDS.
A Health System Under Strain
For weeks, Batswana have voiced growing concerns over the state of public healthcare. Reports of empty shelves in public clinics, delays in treatment, and shortages of critical chronic medication have sparked alarm across the nation.
Botswana, which has long prided itself on its progressive HIV/AIDS response, now finds itself facing a serious setback. ARVs, which millions rely on for survival, are among the medicines reportedly in short supply. The situation threatens to reverse gains made in controlling the epidemic, one of the country’s most pressing health challenges.
Mobilising Funds for Urgent Relief
In response, the government has tasked the Botswana Development Corporation (BDC) with securing the necessary funding to stabilise the health system. According to BDC Managing Director Oteng Keabetswe, the corporation will pursue a blend of local and international investment to raise the required 2.5 billion pula.
“Our mandate is to ensure that this funding is secured so the government can adequately deliver healthcare services to Batswana,” Keabetswe said, underscoring the urgency of the mission.
The funds are expected to go toward procuring medicines, strengthening supply chains, and restoring capacity in public clinics and hospitals.
A Declaration with Weight
President Boko’s decision to declare a public health emergency highlights the scale of the crisis. While Botswana has declared health emergencies in the past most recently during the COVID-19 pandemic this is the first time in years that the nation’s healthcare infrastructure has been so visibly strained.
The declaration provides the government with legal and administrative flexibility to redirect resources, streamline procurement, and attract international assistance more rapidly.
The HIV/AIDS Dimension
Botswana has one of the highest HIV prevalence rates in the world, with an estimated 20% of adults living with HIV. The country has, until now, been hailed globally for its robust treatment programmes and widespread ARV access.
The current shortage, however, threatens to erode decades of progress. Advocacy groups warn that any interruption in ARV treatment could have devastating effects, not only for individual patients but for public health more broadly, as it increases the risk of drug resistance and transmission.
Seeking Partnerships and Long-Term Solutions
While the immediate focus is on emergency funding, the crisis has also reignited debate on Botswana’s long-term health system resilience. Analysts suggest the country will need to invest more in local pharmaceutical production, supply chain management, and funding buffers to avoid similar crises in the future.
Keabetswe emphasised that the fundraising effort is not merely a stopgap:
“This is about building sustainable capacity so that our healthcare system is never again this vulnerable.”
International partners, including donor agencies and global health organisations, are expected to play a role in bridging the funding gap.
A Test for the New Administration
For President Boko, who took office earlier this year, the health crisis represents an early test of leadership. His administration’s ability to mobilise resources, restore confidence, and stabilise the health sector will be closely watched both domestically and abroad.
As September approaches, the urgency grows. For ordinary Batswana, the hope is simple: that shelves in clinics and hospitals will be restocked, treatment will resume without disruption, and the country can once again live up to its reputation as a continental leader in healthcare.
About the Author
